nimodipine has been researched along with Proliferative Vitreoretinopathy in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimodipine can inhibit the expression of VEGF at certain degrees." | 1.32 | [Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy]. ( Deng, DY; Han, LR; Kong, Y; Peng, YJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, Y | 1 |
| Han, LR | 1 |
| Peng, YJ | 1 |
| Deng, DY | 1 |
1 other study available for nimodipine and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
[Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy].
Topics: Animals; Calcium Channel Blockers; Nimodipine; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal | 2004 |